227
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis

, , , & ORCID Icon
Pages 2567-2575 | Received 10 May 2022, Accepted 24 Sep 2022, Published online: 12 Oct 2022

References

  • Yanagisawa S, Ichinose M. Definition and diagnosis of asthma-COPD overlap (ACO). Allergol Int. 2018;67(2):172–178. doi:10.1016/j.alit.2018.01.002
  • Hosseini M, Almasi-Hashiani A, Sepidarkish M, Maroufizadeh S. Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis. Respir Res. 2019;20(1):229. doi:10.1186/s12931-019-1198-4
  • Global Initiative for Asthma. Global strategy for asthma management and prevention; 2021. Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf. Accessed 5 June, 2021.
  • Nuñez A, Sarasate M, Loeb E, Esquinas C, Miravitlles M, Barrecheguren M. Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO). COPD. 2019;16(1):1–7. doi:10.1080/15412555.2019.1575802
  • Fahy JV. Type 2 inflammation in asthma – present in most, absent in many. Nat Rev Immunol. 2015;15(1):57–65. doi:10.1038/nri3786
  • Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011
  • Fu JJ, Gibson PG, Simpson JL, et al. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87(1):63–74. doi:10.1159/000352053
  • Inoue H, Nagase T, Morita S, et al. Prevalence and characteristics of asthma-COPD overlap syndrome identified by a stepwise approach. Int J Chron Obstruct Pulmon Dis. 2017;12:1803–1810. doi:10.2147/COPD.S133859
  • Kawamatawong T, Charoenniwassakul S, Rerkpattanapipat T. The asthma and chronic obstructive pulmonary disease overlap syndrome in tertiary care setting Thailand. Asia Pac Allergy. 2017;7(4):227–233. doi:10.5415/apallergy.2017.7.4.227
  • Shirai T, Hirai K, Gon Y, et al. Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap. J Allergy Clin Immunol Pract. 2019;7(1):134–145.e1. doi:10.1016/j.jaip.2018.06.015
  • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2021 report); 2020. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20. Accessed 5 June, 2021.
  • Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. doi:10.1177/0962280216669183
  • Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. doi:10.1186/1471-2288-14-135
  • Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane; 2021. Available from: www.training.cochrane.org/handbook. Accessed October 5, 2022.
  • Rostom A, Dube C, Cranney A, et al.; Celiac Disease. Agency for healthcare research and quality (US). Rockville (MD); 2004. Available from: https://www.ncbi.nlm.nih.gov/books/NBK35156/. Accessed 5 June, 2021.
  • Doidge JC, Harron KL. Reflections on modern methods: linkage error bias. Int J Epidemiol. 2019;48(6):2050–2060. doi:10.1093/ije/dyz203
  • Fu JJ, McDonald VM, Gibson PG, et al. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316–324. doi:10.4168/aair.2014.6.4.316
  • Lee HY, Kang JY, Yoon HK, et al. Clinical characteristics of asthma combined with COPD feature. Yonsei Med J. 2014;55(4):980–986. doi:10.3349/ymj.2014.55.4.980
  • Carpagnano GE, Lacedonia D, Carone M, et al. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases. J Breath Res. 2016;10(2):026005. doi:10.1088/1752-7155/10/2/026005
  • Cosio BG, Soriano JB, López-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149(1):45–52. doi:10.1378/chest.15-1055
  • Gao J, Iwamoto H, Koskela J, et al. Characterization of sputum biomarkers for asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;11:2457–2465. doi:10.2147/COPD.S113484
  • Goto T, Camargo CA, Hasegawa K. Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and nutrition examination survey, 2007–2012. Int J Chron Obstruct Pulmon Dis. 2016;11:2149–2155. doi:10.2147/COPD.S110879
  • Kalinina EP, Denisenko YK, Vitkina TI, et al. The mechanisms of the regulation of immune response in patients with comorbidity of chronic obstructive pulmonary disease and asthma. Can Respir J. 2016;2016:4503267. doi:10.1155/2016/4503267
  • Bai JW, Mao B, Yang WL, et al. Asthma-COPD overlap syndrome showed more exacerbations however lower mortality than COPD. QJM. 2017;110(7):431–436. doi:10.1093/qjmed/hcx005
  • Gao J, Zhou W, Chen B, et al. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2017;12:2703–2710. doi:10.2147/COPD.S142466
  • Kodama Y, Kishimoto Y, Muramatsu Y, et al. Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease, asthma-COPD overlap syndrome and bronchial asthma. Clin Respir J. 2017;11(6):915–924. doi:10.1111/crj.12436
  • Kurashima K, Takaku Y, Ohta C, et al. Smoking history and emphysema in asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2017;12:3523–3532. doi:10.2147/COPD.S149382
  • Lacedonia D, Palladino GP, Foschino-Barbaro MP, et al. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype. Int J Chron Obstruct Pulmon Dis. 2017;12:1811–1817. doi:10.2147/COPD.S130616
  • Boulet LP, Boulay MÈ, Dérival JL, et al. Asthma-COPD Overlap Phenotypes and Smoking: comparative features of asthma in smoking or non-smoking patients with an incomplete reversibility of airway obstruction. COPD. 2018;15(2):130–138. doi:10.1080/15412555.2017.1395834
  • de Llano LP, Cosío BG, Iglesias A, et al. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018;13:591–601. doi:10.2147/COPD.S153694
  • Duong-Quy S, Tran Van H, Vo Thi Kim A, et al. Clinical and functional characteristics of subjects with asthma, COPD, and asthma-COPD overlap: a multicentre study in Vietnam. Can Respir J. 2018;2018:1732946. doi:10.1155/2018/1732946
  • Ekerljung L, Mincheva R, Hagstad S, et al. Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample. J Asthma. 2018;55(5):461–469. doi:10.1080/02770903.2017.1339799
  • Guo Y, Hong C, Liu Y, et al. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome. Medicine. 2018;97(23):e10857. doi:10.1097/MD.0000000000010857
  • Jo YS, Kwon SO, Kim J, et al. Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap. J Thorac Dis. 2018;10(8):5047–5056. doi:10.21037/jtd.2018.07.86
  • Oh JY, Lee YS, Min KH, et al. Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study. Int J Chron Obstruct Pulmon Dis. 2018;13:1809–1818. doi:10.2147/COPD.S163189
  • Ojanguren I, Moullec G, Hobeika J, et al. Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma. PLoS One. 2018;13(3):e0193144. doi:10.1371/journal.pone.0193144
  • Park HY, Lee SY, Kang D, et al. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort. Respir Res. 2018;19(1):36. doi:10.1186/s12931-018-0737-8
  • Shi F, Qiu C, Yu J, et al. Comparison of fractional exhaled nitric oxide in elderly patients with asthma-chronic obstructive pulmonary disease overlap and other airway inflammatory diseases. Iran J Allergy Asthma Immunol. 2018;17(3):232–239.
  • Takayama Y, Ohnishi H, Ogasawara F, et al. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap. Int J Chron Obstruct Pulmon Dis. 2018;13:2525–2532. doi:10.2147/COPD.S167600
  • Wang J, Lv H, Luo Z, et al. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD. Respir Res. 2018;19(1):47. doi:10.1186/s12931-018-0755-6
  • Cai C, Bian X, Xue M, et al. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study. Int J Chron Obstruct Pulmon Dis. 2019;14:1769–1778. doi:10.2147/COPD.S207023
  • Chen FJ, Lin GP, Huang XY, et al. Evaluation of the characteristics of asthma in severe and extremely severe COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:2663–2671. doi:10.2147/COPD.S225258
  • Kyogoku Y, Sugiura H, Ichikawa T, et al. Nitrosative stress in patients with asthma-chronic obstructive pulmonary disease overlap. J Allergy Clin Immunol. 2019;144(4):972–983.e14. doi:10.1016/j.jaci.2019.04.023
  • Park SY, Jung H, Kim JH, et al. Longitudinal analysis to better characterize Asthma-COPD overlap syndrome: findings from an adult asthma cohort in Korea (COREA). Clin Exp Allergy. 2019;49(5):603–614. doi:10.1111/cea.13339
  • Sevimli N, Yapar D, Türktaş H. The prevalence of asthma-COPD overlap (ACO) among patients with asthma. Turk Thorac J. 2019;20(2):97–102. doi:10.5152/TurkThoracJ.2018.18055
  • Backer V, Klein DK, Bodtger U, et al. Clinical characteristics of the BREATHE cohort – a real-life study on patients with asthma and COPD. Eur Clin Respir J. 2020;7(1):1736934. doi:10.1080/20018525.2020.1736934
  • Ding Q, Sun S, Zhang Y, et al. Serum IL-8 and VEGFA are two promising diagnostic biomarkers of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2020;15:357–365. doi:10.2147/COPD.S233461
  • Gava G, Núñez A, Esquinas C, et al. Analysis of blood biomarkers in patients with chronic obstructive pulmonary disease (COPD) and with asthma-COPD overlap (ACO). COPD. 2020;17(3):306–310. doi:10.1080/15412555.2020.1761314
  • Ghosh N, Choudhury P, Kaushik SR, et al. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO). Respir Res. 2020;21(1):126. doi:10.1186/s12931-020-01390-4
  • Kang J, Zheng J, Cai B, et al. Current situation of asthma-COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study. Ther Adv Respir Dis. 2020;14:1753466620961699. doi:10.1177/1753466620961699
  • Kobayashi S, Hanagama M, Ishida M, et al. Clinical characteristics and outcomes of patients with asthma-COPD overlap in Japanese patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2923–2929. doi:10.2147/COPD.S276314
  • Kubysheva N, Boldina M, Eliseeva T, et al. Relationship of serum levels of IL-17, IL-18, TNF-α, and lung function parameters in patients with COPD, asthma-COPD overlap, and bronchial asthma. Mediators Inflamm. 2020;2020:4652898. doi:10.1155/2020/4652898
  • Li M, Yang T, He R, et al. The value of inflammatory biomarkers in differentiating asthma-COPD overlap from COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:3025–3037. doi:10.2147/COPD.S273422
  • Lim JU, Kim DK, Lee MG, et al. Clinical characteristics and changes of clinical features in patients with asthma-COPD overlap in Korea according to different diagnostic criteria. Tuberc Respir Dis. 2020;83(Supple1):S34–S45. doi:10.4046/trd.2020.0031
  • Queiroz APA, Fonseca FR, Rê A, et al. Clinical, laboratory, and functional characteristics of asthma-COPD overlap in patients with a primary diagnosis of COPD. J Bras Pneumol. 2020;47(1):e20200033. doi:10.36416/1806-3756/e20200033
  • Chen YC, Tsai YH, Wang CC, et al. Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes. Sci Rep. 2021;11(1):5022. doi:10.1038/s41598-021-83185-1
  • Shi B, Li W, Hao Y, et al. Characteristics of inflammatory phenotypes among patients with asthma: relationships of blood count parameters with sputum cellular phenotypes. Allergy Asthma Clin Immunol. 2021;17(1):47. doi:10.1186/s13223-021-00548-z
  • Toyota H, Sugimoto N, Kobayashi K, et al. Comprehensive analysis of allergen-specific IgE in COPD: mite-specific IgE specifically related to the diagnosis of asthma-COPD overlap. Allergy Asthma Clin Immunol. 2021;17(1):13. doi:10.1186/s13223-021-00514-9
  • Lei J, Yang T, Liang C, et al. Comparison of clinical characteristics and short-term prognoses within hospitalized chronic obstructive pulmonary disease patients comorbid with asthma, bronchiectasis, and their overlaps: findings from the ACURE registry. Front Med. 2022;9:817048. doi:10.3389/fmed.2022.817048
  • Tamura K, Shirai T, Hirai K, et al. Mucus plugs and small airway dysfunction in asthma, COPD, and asthma-COPD overlap. Allergy Asthma Immunol Res. 2022;14(2):196–209. doi:10.4168/aair.2022.14.2.196
  • Hegewald MJ. Diffusing capacity. Clin Rev Allergy Immunol. 2009;37(3):159–166. doi:10.1007/s12016-009-8125-2
  • Enright MP. Office-based DLCO tests help pulmonologists to make important clinical decisions. Respir Investig. 2016;54(5):305–311. doi:10.1016/j.resinv.2016.03.006
  • Fujino N, Sugiura H. ACO (asthma-COPD overlap) is independent from COPD, a case in favor: a systematic review. Diagnostics. 2021;11(5):859. doi:10.3390/diagnostics11050859
  • Novosad J, Krčmová I. Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: where do we stand today? Int J Immunopathol Pharmacol. 2020;34:2058738420942386. doi:10.1177/2058738420942386
  • Hersh CP, Zacharia S, Chelvan R P, et al. Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2020;7(1):1–12. doi:10.15326/jcopdf.7.1.2019.0138
  • Tashkin DP, Wechsler ME. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018;13:335–349. doi:10.2147/COPD.S152291
  • Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469–1485. doi:10.1016/j.cell.2021.02.016
  • Zhou XL, Zhao LY. Comparison of clinical features and outcomes for asthma-COPD overlap syndrome vs. COPD patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25(3):1495–1510. doi:10.26355/eurrev_202102_24857